An attempt was made to create a panel of markers, including two genes (C-MYC and CCND2) common to both the pathways, along with other correlated genes, which was evaluated in a larger cohort of either condition for their usefulness in the detection of neoplasia in both CRC conditions. Here, CCND2 is linked to colorectal carcinoma.